[Ip-health] Malaysia's patent licensing for health & the hep C cure

Peter Maybarduk pmaybarduk at citizen.org
Tue Apr 16 08:59:48 PDT 2019

During the U.S. government's Special 301 hearing this year, investigating countries' intellectual property practices, PhRMA criticized patent licensing in general and Malaysia in particular, for making available affordable generic versions of the hepatitis C cure. U.S. government representatives asked several witnesses about Malaysia's policy. In our view, Malaysia has taken important steps to protect public health - and the world can learn from it: 

-Peter, Public Citizen
Washington DC

More information about the Ip-health mailing list